The last stage before commercializing this unique and Innovative technology for diagnosing breast cancer
ART Advanced Research Technologies Inc.(TSX:ARA), in collaboration with the Cedars Breast Clinic of the McGill University Health Centre (MUHC), today launched a pivotal clinical study, North American in scope, the final stage prior to commercializing SoftScan®, an optical breast imaging system designed to improve the diagnosis and treatment of breast cancer.
